ReviewBreast cancer research and treatment2024

Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast.

Camila Vitola Pasetto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.